Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2023-03-01 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2023-03-01 English
6-K
Foreign Filer Report
2023-02-28 English
Share Issue/Capital Change 2023
Share Issue/Capital Change Classification · 1% confidence The document is a 'Company Announcement' detailing a 'Capital Increase in Genmab as a Result of Employee Warrant Exercise'. It specifies the number of shares issued, the subscription prices, the total proceeds (DKK 31.8 million), and the resulting total share capital. This content directly relates to changes in the company's capital structure due to the exercise of employee stock options/warrants. This aligns perfectly with the definition for 'Capital/Financing Update' (Code: CAP). Although it mentions a warrant exercise, it is not a general share repurchase (POS) or a general share issue announcement (SHA), but specifically a financing/capital structure event resulting from employee compensation instruments.
2023-02-28 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 1% confidence The document is a formal company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, and the resulting change in total share capital. This falls directly under the category of share issues or capital changes.
2023-02-28 English
6-K
Foreign Filer Report
2023-02-28 English
6-K
Foreign Filer Report
2023-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.